Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
- Terry's Desk
- Jun 22
- 1 min read
Updated: Jun 26
What if the way we've been studying GPCRs—arguably the most important drug targets in pharmacology—has been wrong… or at least, incomplete?
In the foundational lesson of Terry’s Corner, Dr. Terry Kenakin invites us to challenge outdated assumptions and step into a new era of drug discovery. With insights from molecular dynamics, biased signaling, and allosteric modulation, this session lays bare the science that’s reshaping how we develop medicines.
Here’s the surprising truth: up to 80% of GPCR-targeted drugs fail—not because of poor chemistry, but because we’ve misunderstood how these shape-shifting proteins truly behave.
Now, Terry is opening the vault. This isn’t theory. It’s 40 years of hard-won insight distilled into accessible, high-impact content designed for learners just starting out.
This is your chance to get ahead of the curve. Join Terry’s Corner and stay updated on the latest in GPCR research—delivered in a format that’s as approachable as it is transformative.
👉 Ready to understand what your molecules are really doing?
Comments